Together, these results suggest that, although CPZ selectively targets AML cells with MT-RTKs mainly through CALM protein depletion, inhibition of other molecules such as DR and 5-HTR might, to some extent, contribute to full anti-AML activities of CPZ depending on cellular contexts. The gene discussed is PICALM; the disease is acute myeloid leukemia.